首頁 > 市場調查報告書 > 製藥

麻醉

市場調查報告書

商品編碼

1461446

七氟醚市場，依應用、配銷通路和地區 - 規模、佔有率、前景和機會分析，2024 年至 2031 年

Sevoflurane Market, by Application, by Distribution Channel, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031

出版日期: 2024年03月12日 | 出版商:

Coherent Market Insights | 英文 150 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到 2024 年，全球七氟醚市值將達到 4.007 億美元，預計在預測期內（2024-2031 年）複合年成長率為 4.4%。

報告範圍		報告詳情
基準年：	2023年	2023/2024 年市場規模：	4.007 億美元
歷史數據：	2019年至2023年	預測期：	2024年至2031年
預測期間 2023/2024 至 2030/2031 年複合成長率：	4.40%	2030/2031 價值預測：	5.422 億美元

2024 年全球七氟醚市場價值（百萬美元），依地區分類

七氟烷是一種具有甜味、不易燃、高度氟化的甲基異丙醚，用作全身麻醉誘導和維持的吸入性麻醉劑。它是繼地氟烷之後起效最快的揮發性麻醉劑。

市場動態

市場參與者專注於推出新技術，以幫助透過吸入器提供麻醉，這可能有助於預測期內全球七氟醚市場的成長。例如，2022 年 4 月，全球領先的醫療技術公司 GE Healthcare 宣布，其 Aisys CS2 麻醉輸送系統上用於全身麻醉輸送的潮氣末 (Et) 控制軟體已獲得 FDA 的上市前批准 (PMA)。和藥物管理局（FDA）。在美國，GE Healthcare 是唯一一家獲準提供具有呼氣末濃度控制的全身麻醉的製造商。

需要麻醉的美容手術數量不斷增加，預計將推動全球七氟醚市場的成長。例如，2022 年 4 月，專門致力於臉部和身體美容整形手術和美容醫學的世界領先協會美容協會發布了年度美容整形手術統計數據，該統計數據顯示，由於使用以下方法獲得的資料，2021 年美國美容整形手術增加協會新的、更準確的數位技術。資料顯示，臉部、乳房和身體的手術數量大幅增加。自 2020 年以來，腹部整形術、豐臀術和抽脂術在美國的受歡迎程度均猛增了 63%。

擴大推出回收吸入麻醉劑的技術預計將推動預測期內的成長。例如，2020 年 7 月，全球無菌藥物生產和交付領域的領導者 Baxter International Inc. 宣布與醫療技術公司 ZeoSys Medical 簽署正式協議，將捕獲和回收麻醉氣體的技術商業化。根據協議條款，百特將擁有全球分銷權和在歐洲以外商業化該技術的獨家許可，以及收購 ZeoSys Medical 的獨家選擇權。

研究的主要特點：

本報告對全球七氟醚市場進行了深入分析，提供了預測期（2024-2031）的市場規模，以 2023 年為基準年。
它闡明了不同區隔市場的潛在收入機會，並解釋了該市場有吸引力的投資主張矩陣。
這項研究還提供了有關市場促進因素、限制因素、機會、新產品發布或批准、區域前景以及領先企業採取的競爭策略的重要見解。
它根據以下參數介紹了全球七氟烷市場的領先參與者 - 公司概況、財務績效、產品組合、地理分佈、分銷策略、主要發展和策略以及未來計劃。
該報告的見解將使行銷人員和公司管理當局能夠就未來的產品推出、技術升級、市場擴張和行銷策略做出明智的決策。
全球七氟醚市場報告迎合了該行業的各種利益相關者，包括投資者、供應商、製造商、分銷商、新進業者和金融分析師。
利害關係人可以透過用於分析全球七氟醚市場的各種策略矩陣輕鬆做出決策。

介紹
北美洲
美國
加拿大
拉丁美洲
巴西
墨西哥
阿根廷
拉丁美洲其他地區
歐洲
德國
英國
法國
義大利
西班牙
俄羅斯
歐洲其他地區
亞太地區
中國
印度
日本
澳洲
韓國
東協
亞太地區其他地區
中東
海灣合作理事會
以色列
中東其他地區
非洲
南非
中非
北非

第 8 章：競爭格局

公司簡介
- Abbott Laboratories
- Baxter
- Piramal Pharma Solutions
- Manus Aktteva Biopharma LLP
- Maruishi Pharmaceutical Co.,Ltd.
- Lunan Pharmaceutical Group
- Abbvie
- Wellona Pharma
- Rewine Pharmaceutical
- Troikaa Pharmaceuticals Limited

第 9 章：分析師建議

命運之輪
分析師觀點
連貫的機會圖

第 10 章：部分

參考
研究方法論

簡介目錄

Product Code: CMI5031

The global sevoflurane market is estimated to be valued at USD 400.7 Mn in 2024 and is expected to exhibit a CAGR of 4.4% during the forecast period (2024-2031).

Report Coverage		Report Details
Base Year:	2023	Market Size in 2023/2024:	US$ 400.7 Mn
Historical Data for:	2019 to 2023	Forecast Period:	2024 to 2031
Forecast Period 2023/2024 to 2030/2031 CAGR:	4.40%	2030/2031 Value Projection:	US$ 542.2 Mn

Global Sevoflurane Market Value (USD MN), by Region, 2024

Sevoflurane is a sweet-smelling, nonflammable, highly fluorinated methyl isopropyl ether that is used as an inhalational anesthetic for general anesthesia induction and maintenance. It is the fastest-acting volatile anesthetic after desflurane.

Market Dynamics

Market players are focused on launching new technology to help delivery of anesthesia through inhalers, this could contribute to the growth of the global sevoflurane market over the forecast period. For instance, in April 2022, GE Healthcare, a leading global medical technology company, announced that its end-tidal (Et) Control software for general anesthesia delivery on its Aisys CS2 Anesthesia Delivery System has received pre-market approval (PMA) from the U.S. Food and Drug Administration (FDA). In the U.S., GE Healthcare is the only manufacturer approved to provide general anesthesia with end-tidal concentration control.

Increasing number of aesthetic surgeries requiring anesthesia, is expected to drive the growth of global sevoflurane market. For instance, in April 2022, The Aesthetic Society, world's leading association dedicated solely to facial and body aesthetic plastic surgery and cosmetic medicine issued its annual Aesthetic Plastic Surgery Statistics, which revealed that aesthetic plastic surgery increased in 2021 in U.S. owing to data acquired using the Society's new, more accurate digital technology. The data shows a large growth in procedures for the face, breasts, and body. Abdominoplasty, buttock augmentation, and liposuction have all seen a 63% surge in popularity since 2020 in U.S. Breast augmentation, augmentation/breast lift, and breast lift/reduction treatments all increased by 48%.

Increasing launches of technology to recycle inhaled anesthetics is expected to fuel the growth over forecast period. For instance, in July 2020, Baxter International Inc., a global leader in the production and delivery of sterile medications, announced a formal agreement with ZeoSys Medical, a medical technology company, to commercialize technology to capture and recycle anesthetic gases. Baxter will have worldwide distribution rights and an exclusive license to commercialize the technology outside of Europe, as well as an exclusive option to acquire ZeoSys Medical, under the terms of the agreement.

Key features of the study:

This report provides an in-depth analysis of global sevoflurane market, provides market size (US$ Million), and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market.
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
It profiles leading players in the global sevoflurane market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
Key companies covered as a part of this study include Abbott Laboratories, Baxter, Piramal Pharma Solutions, Manus Aktteva Biopharma LLP, Maruishi Pharmaceutical Co.,Ltd., Lunan Pharmaceutical Group, Abbvie, Wellona Pharma, Rewine Pharmaceutical, and Troikaa Pharmaceuticals Limited
Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
The global sevoflurane market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision making through various strategy matrices used in analyzing the global sevoflurane market.

Detailed Segmentation:

Global Sevoflurane Market, By Application:
- Induction
- Maintenance
Global Sevoflurane Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Sevoflurane Market, By Region:
- North America
- Latin America
- Europe
- Asia Pacific
- Middle East
- Africa
Company Profiles
- Abbott Laboratories
- Baxter
- Piramal Pharma Solutions
- Manus Aktteva Biopharma LLP
- Maruishi Pharmaceutical Co.,Ltd.
- Lunan Pharmaceutical Group
- Abbvie
- Wellona Pharma
- Rewine Pharmaceutical
- Troikaa Pharmaceuticals Limited

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Overview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Application
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
Impact Analysis
Porter's Analysis
Industry Trends
Key Highlights
Epidemiology
Reimbursement Scenario
Regulatory Scenario
Product Launch and Approvals
Acquisition and Collaboration Scenario

4. Global Sevoflurane Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Impact of COVID-19 on demand and supply of sevoflurane
Impact of COVID-19 on the overall healthcare sector

5. Global Sevoflurane Market, By Application, 2017-2030 (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Induction
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Maintenance
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Sevoflurane Market, By Distribution Channel, 2017-2030 (US$ Million)

Introduction
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018-2030
- Segment Trends
Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Sevoflurane Market, By Region, 2017-2030 (US$ Million)

Introduction
- Market Share Analysis, By Region, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2018-2030
- Regional Trends
North America
- Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Mn)
U.S.
Canada
Latin America
- Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
Brazil
Mexico
Argentina
Rest of Latin America
Europe
- Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
- Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
- Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Country, 2017-2030 (US$ Mn)
GCC
Israel
Rest of Middle East
Africa
- Market Size and Forecast, By Application, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2017-2030 (US$ Mn)
- Market Size and Forecast, By Country/Region, 2017-2030 (US$ Mn)
South Africa
Central Africa
North Africa

8. Competitive Landscape

Company Profiles
- Abbott Laboratories*
Company Overview
Product Portfolio
Financial Performance
Recent Developments/Updates
Strategies
- Baxter
- Piramal Pharma Solutions
- Manus Aktteva Biopharma LLP
- Maruishi Pharmaceutical Co.,Ltd.
- Lunan Pharmaceutical Group
- Abbvie
- Wellona Pharma
- Rewine Pharmaceutical
- Troikaa Pharmaceuticals Limited